Document Detail

Endothelin receptor antagonists - their role in pulmonary medicine.
MedLine Citation:
PMID:  22099418     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: Understanding of the function of endothelin-1 in the pathophysiology of endothelial disease, in particular pulmonary arterial hypertension (PAH), has paved the way for the development of endothelin-receptor antagonists (ERAs) and explains the leading role they now play in the treatment armamentarium for this disease.
BACKGROUND: Three active ERA drugs (bosentan, sitaxentan, ambrisentan) are currently approved for the treatment of PAH in France. Several randomised clinical trials have demonstrated their efficacy and safety in PAH.
PERSPECTIVES AND CONCLUSION: Besides its vasoconstrictor effect, endothelin-1 (ET-1) plays a pivotal role in cell proliferation and apoptosis. ERAs are innovative drugs potentially useful in some pulmonary disorders such as idiopathic pulmonary fibrosis or systemic sclerosis, even though the preliminary results published remain insufficient or controversial.
CONCLUSION: ERAs play a major role in the management of pulmonary vascular disease. Other drugs, still under study, could prove useful in the treatment of infiltrating pneumonias.
S Boniface; M Reynaud-Gaubert
Related Documents :
19109028 - Pulmonary artery agenesis and kommerell's diverticulum presenting with hemoptysis.
19338468 - Combination of preoperative embolization and surgery in the treatment of a giant congen...
9667408 - Familial non-immune hydrops fetalis and congenital pulmonary lymphangiectasia.
10817858 - Concomitant management of airway and its adjacent vascular pathology in addition to rep...
18809278 - Distal graft anastomosis using a tapered elephant trunk in an inflammatory aneurysm.
11583708 - Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries.
Publication Detail:
Type:  Journal Article     Date:  2011-10-27
Journal Detail:
Title:  Revue des maladies respiratoires     Volume:  28     ISSN:  1776-2588     ISO Abbreviation:  Rev Mal Respir     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8408032     Medline TA:  Rev Mal Respir     Country:  France    
Other Details:
Languages:  eng     Pagination:  e94-e107     Citation Subset:  IM    
Copyright Information:
Copyright © 2011. Published by Elsevier Masson SAS.
Cabinet de pneumologie, 4, avenue de Delphes, 13006 Marseille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly.
Next Document:  Snapshot of Quantiferon TB gold testing in Northern Mexico.